Physical dependence on Ultram® (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur

This publication has 12 references indexed in Scilit:

• A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States
  Drug and Alcohol Dependence, 1999
• Postmarketing Surveillance and Adverse Drug Reactions
  Published by American Medical Association (AMA) ,1999
• Fluoxetine withdrawal?
  American Journal of Psychiatry, 1995
• Neuroleptic Withdrawal in Schizophrenic Patients
  Archives of General Psychiatry, 1995
• Withdrawal Phenomena Associated with Antidepressant and Antipsychotic Agents
  Drug Safety, 1994
• Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems
  JAMA, 1993
• Atypical Withdrawal Syndrome (Organic Delusional Syndrome) Secondary to Oxycodone Detoxification
  Journal of Clinical Psychopharmacology, 1988
• Adverse-Drug-Reaction Monitoring
  New England Journal of Medicine, 1986
• Abrupt cessation of treatment in hypertension: Consideration of clinical features, mechanisms, prevention and management of the discontinuation syndrome
  American Heart Journal, 1981
• Withdrawal syndromes and the cessation of antihypertensive therapy
  Archives of internal medicine (1960), 1981